DscRNA-seq has increased substantially the throughput of single-cell capture and library preparation 1,2 , enabling the simultaneous transcriptomic profiling of thousands of cells. Improvements in biochemistry 3,4 and microfluidics 5, 6 continue to increase the number of cells and transcripts profiled per experiment. But for differential expression and population genetics studies, sequencing thousands of cells each from many individuals would better capture inter-individual variability than sequencing more cells from a few individuals. However, in standard workflows, dscRNA-seq of many samples in parallel remains challenging to implement. If the genetic identity of each cell could be determined, pooling cells from different individuals in one microfluidic run would result in lower per-sample library preparation cost and eliminate confounding effects. Furthermore, if droplets containing multiple cells from different individuals could be detected, pooled cells could be loaded at higher concentrations, enabling additional reduction in per-cell library preparation cost.
A r t i c l e s
DscRNA-seq has increased substantially the throughput of single-cell capture and library preparation 1,2 , enabling the simultaneous transcriptomic profiling of thousands of cells. Improvements in biochemistry 3,4 and microfluidics 5, 6 continue to increase the number of cells and transcripts profiled per experiment. But for differential expression and population genetics studies, sequencing thousands of cells each from many individuals would better capture inter-individual variability than sequencing more cells from a few individuals. However, in standard workflows, dscRNA-seq of many samples in parallel remains challenging to implement. If the genetic identity of each cell could be determined, pooling cells from different individuals in one microfluidic run would result in lower per-sample library preparation cost and eliminate confounding effects. Furthermore, if droplets containing multiple cells from different individuals could be detected, pooled cells could be loaded at higher concentrations, enabling additional reduction in per-cell library preparation cost.
Here we develop an experimental protocol for multiplexed dscRNA-seq and a computational algorithm, demuxlet, that harnesses genetic variation to determine the genetic identity of each droplet containing a single cell (singlet) and identify droplets containing two cells from different individuals (doublets) (Fig. 1a) . While strategies to demultiplex cells from different species 1,2,7 or host and graft samples 7 have been reported, simultaneously demultiplexing and detecting doublets from more than two individuals has not been possible. Inspired by models and algorithms developed for detecting contamination in DNA sequencing 8 , demuxlet is fast, accurate, scalable, and compatible with standard input formats 7, 9, 10 .
Demuxlet implements a statistical model for evaluating the likelihood of observing RNA-seq reads overlapping a set of SNPs from each cell-containing droplet. Given a set of best-guess genotypes or genotype probabilities obtained from genotyping, imputation or sequencing, demuxlet uses maximum likelihood to determine the most likely donors for each droplet using a mixture model. A small number of reads overlapping common SNPs is sufficient to accurately identify each droplet. For a pool of eight individuals and a set of uncorrelated SNPs, each with 50% minor allele frequency (MAF), four reads overlapping
Multiplexed droplet single-cell rNA-sequencing using natural genetic variation A r t i c l e s SNPs are sufficient to uniquely assign a singlet to the donor of origin (Fig. 1b) and 20 reads overlapping SNPs can distinguish every sample with >98% probability in simulation (Supplementary Fig. 1 ). We note that by multiplexing even a small number of individuals, the probability that a doublet contains cells from different individuals is very high (1 − 1/N, for example, 87.5% for N = 8 samples) (Fig. 1c) . If a 1,000-cell run without multiplexing results in 990 singlets with a 1% undetected doublet rate, multiplexing 1,570 cells each from 63 samples can theoretically achieve the same rate of undetected doublets, producing up to 37-fold more singlets (36, 600) if the sample identity of every droplet can be perfectly demultiplexed (Supplementary Fig. 2 ). Profiling 30,000 cells multiplexed from 26 individuals can theoretically generate 23-fold more singlets at the same effective doublet rate, minimizing the effects of sequencing doublets (Supplementary Fig. 3) .
We first assessed the performance of multiplexed dscRNA-seq through simulation. The ability to demultiplex droplets is a function of the number of individuals multiplexed, the depth of sequencing or number of read-overlapping SNPs, and the relatedness of multiplexed individuals. We simulated 6,145 droplets (5,837 singlets and 308 doublets) from 2-64 individuals from the 1000 Genomes Project 11 . We show that 50 SNPs per droplet allows demultiplexing of 97% of singlets and identification of 92% of doublets in pools of up to 64 individuals ( Supplementary Figs. 4-5) . Simulating a range of sequencing depths, we determined that 50 SNPs can be obtained with as few as 1,000 unique molecular identifiers (UMIs) per droplet (Supplementary Fig. 6 ), and that the recommended sequencing depths of standard dscRNA-seq workflows would capture hundreds of SNPs. To assess dependence on the relatedness of multiplexed individuals, we simulated 6,145 singlets from a set of eight related individuals from 1000 Genomes 11 . In this simulation, 50 SNPs per singlet would allow demuxlet to correctly assign over 98% of singlet (Supplementary Fig. 7) . These results suggest optimal multiplexed designs where cells from tens of unrelated individuals should be pooled, loaded at concentrations 2-10× higher than standard workflows, and sequenced to at least 1,000 UMIs per droplet.
We evaluated the performance of demuxlet by analyzing a pool of peripheral blood mononuclear cells (PBMCs) from eight lupus patients. By sequential pairwise pooling, three pools of equimolar concentrations of cells were generated (W1: patients S1-S4, W2: patients S5-S8 and W3: patients S1-S8), and each were loaded in a well on a 10× Chromium instrument (Fig. 2a) . 3,645 (W1), 4,254 (W2), and 6,205 (W3) cell-containing droplets were sequenced to an average depth of 51,000, 39,000, and 28,000 reads per droplet.
In wells W1, W2, and W3, demuxlet identified 91% (3,332/3,645), 91% (3,864/4,254), and 86% (5,348/6,205) of droplets as singlets (likelihood ratio test, L(singlet)/L(doublet) > 2), of which 25% (±2.6%), 25% (±4.6%) and 12.5% (±1.4%) mapped to each donor, consistent with equal mixing of individuals in each well. From wells W1 and W2, each containing cells from two disjoint sets of four individuals, we estimated a demultiplexing error rate (number of cells assigned to individuals not in the pool) of less than 1% of singlets (W1: 2/3,332, W2: 0/3,864) (Fig. 2b) .
We next assessed the ability of demuxlet to detect doublets in both simulated and real data. 466/3,645 (13%) droplets from W1 were simulated as synthetic doublets by setting the cellular barcodes of 466 droplets, each from individuals S1 and S2, to be the same. Applied to simulated data, demuxlet identified 91% (426/466) a c b of synthetic doublets as doublets or ambiguous, correctly recovering the sample identity of both cells in 403/426 (95%) doublets (Supplementary Fig. 8 ). Applied to real data from W1, W2, and W3, demuxlet identified 138/3,645, 165/4,254, and 384/6,205 doublets corresponding to doublet rates of 5.0%, 5.2%, and 7.1%, consistent with the expected doublet rates estimated from mixed-species experiments (Fig. 2c) . Demultiplexing of pooled samples allows for the statistical and visual comparisons of individual-specific dscRNA-seq profiles. Singlets identified by demuxlet in all three wells cluster into known immune cell types (Fig. 2d ) and are correlated with bulk RNA-sequencing of sorted cell populations (R = 0.76 -0.92) (Supplementary Fig. 9 ). For the same individuals from different wells, t-distributed stochastic neighbor embedding (t-SNE) of dscRNA-seq data are qualitatively consistent, and estimates of cell type proportions are highly correlated (R = 0.99) ( Fig. 2e and Supplementary Fig. 10 ). Further, t-SNE projections of the pool and each individual are not confounded by well-to-well effects (Supplementary Fig. 11a ). While six genes were differentially expressed between wells W1 and W2 (DESeq2 on pseudobulk counts, FDR < 0.05), only two genes were differentially expressed between W1 and W2 individuals in well W3 (FDR < 0.05) (Supplementary Fig. 11b ), suggesting multiplexing reduces technical effects owing to separate sample processing 12, 13 .
We used multiplexed dscRNA-seq to characterize the cell-type specificity and inter-individual variability of response to IFN-β, a potent cytokine that induces genome-scale changes in the transcriptional profiles of immune cells 14, 15 . From each of eight lupus patients, PBMCs were activated with recombinant IFN-β or left untreated for 6 h, a time point we previously found to maximize the expression of interferon-sensitive genes in dendritic cells and T cells 16, 17 . Two pools, IFN-β-treated and control, were prepared with the same number of cells from each individual and loaded onto the 10× Chromium instrument.
We obtained 14,619 (control) and 14,446 (stimulated) cell-containing droplets, of which demuxlet identified 83% (12,138) and 84% (12,167), respectively, as singlets. The estimated doublet rate of 10.9% in each condition is consistent with predicted rates (Fig. 2c) , and the observed and expected frequencies of doublets for each pair of individuals were highly correlated (R = 0.98) (Supplementary Fig. 12 ). Detected doublets form distinct clusters near the periphery of other clusters defined by cell type (Supplementary Fig. 13 ).
Demultiplexing individuals enables the use of the eight individuals within each pool as biological replicates to quantitatively assess cell-type-specific IFN-β responses in PBMCs. Consistent with previous reports from bulk RNA-sequencing data, IFN-β stimulation induces widespread transcriptomic changes observed as a shift in A r t i c l e s the t-SNE projections of singlets 14 (Fig. 3a) . As expected, IFN-β did not affect cell type proportions between control and stimulated cells (Supplementary Fig. 14) , and these were consistent with flow cytometry measurements (R = 0.88) (Supplementary Fig. 15 ). Estimates of abundances for ~2,000 homologous genes in each cell type and condition correlated with similar data from mice ( Supplementary Fig. 16 ).
We identified 3,055 differentially expressed genes abs(logFC) > 1, FDR < 0.05) in at least one cell type (Supplementary Table 1) . For 709 genes, estimates of fold change in response to IFN-β stimulation in myeloid and CD4 + cells were consistent with estimates in monocyte-derived dendritic cells 18 and CD4 + T cells 17 , respectively (Supplementary Fig. 17 ) and correlated with qPCR results of sorted CD4 + T cells (Supplementary Fig. 18 ). Differentially expressed genes clustered into modules of cell-type-specific responses enriched for distinct gene regulatory programs ( Fig. 3b and Supplementary Table 2) . For example, genes upregulated in all leukocytes (Cluster III: 401 genes, abs(logFC) > 1, FDR < 0.05) or only in myeloid cells (Cluster I: 767 genes, abs(logFC) > 1, FDR < 0.05) were enriched for general antiviral response (e.g., KEGG Influenza A: Cluster III P < 1.6 × 10 −5 ), chemokine signaling (Cluster I P < 7.6 × 10 −3 ), and pathways active in systemic lupus erythematosus (Cluster I P < 4.4 × 10 −3 ). The five clusters of downregulated genes were enriched for antibacterial response (KEGG Legionellosis: Cluster II monocyte down P < 5.5 × 10 −3 ) and natural-killer-cell-mediated toxicity (Cluster IV NK/T H cell down: P < 3.6 × 10 −2 ). The analysis of multiplexed dscRNA-seq data recovers cell-type-specific gene regulatory programs affected by interferon stimulation consistent with published IFN-β signatures in mouse and humans 14 . Over all PBMCs, the variance of mean expression across individuals was higher than the variance across synthetic replicates whose cells were randomly sampled (Lin's concordance = 0.022, Pearson correlation = 0.69, Fig. 3c ). The variance across synthetic replicates A r t i c l e s whose cells were randomly sampled; matching for cell type proportions was more concordant with the variance across individuals (Lin's concordance = 0.54, Pearson correlation = 0.78, Fig. 3c,d) , suggesting a contribution of cell type composition on expression variability. However, for each cell type, the variance across individuals 12, 14, 19 was also higher than the variance across synthetic replicates (Lin's concordance = 0.007 − 0.20), suggesting additional inter-individual variability not due to cell type composition ( Supplementary  Fig. 19 ). In CD14 + CD16 -monocytes, the correlation of mean expression between pairs of synthetic replicates from the same individual (>99%) is greater than from different individuals (~97%), further indicating inter-individual variation beyond sampling (Fig. 3e) . We found 15 to 827 genes with statistically significant inter-individual variability in control cells and 7 to 613 in stimulated cells (Pearson correlation, FDR < 0.05), with most found in classical monocytes (cM) and CD4 + helper T (T H ) cells. Inter-individual variable genes in stimulated cM and to a lesser extent in T H cells (P < 9.3 × 10 −4 and 4.5 × 10 −2 , hypergeometric test, Fig. 3f ) were enriched for differentially expressed genes, consistent with our previous discovery of more IFN-β response-expression quantitative trait loci (eQTLs) in monocyte-derived dendritic cells than in CD4 + T cells 16, 17 .
Comparing these genes to 407 genes previously profiled in bulk monocyte-derived dendritic cells, we found the proportion of variance explained by inter-individual variability was correlated more strongly in myeloid cells after stimulation (R = 0.26 − 0.3) than before (R = 0.05 − 0.19).
To map genetic variants associated with cell type proportions and cell-type-specific expression using multiplexed dscRNA-seq, we sequenced an additional 15,250 (7 donors), 22,619 (8 donors), and 25,918 droplets (15 donors; 8 lupus patients, 5 rheumatoid arthritis patients, and 2 healthy controls). Demuxlet identified 71% (10,766/15,250), 73% (16,618/22,619), and 60% (15,596/25,918) of droplets, respectively, as singlets, correctly assigning 99% of singlets from the first two pools, W1 (10,740/10,766) and W2 (16,616/16,618) . The estimated doublet rates of 18%, 18%, and 25% are consistent with the increased concentrations of loaded cells (Fig. 2c) . Similar to the IFN-β stimulation experiment, we found that expression variability was determined by variability in cell type proportion (Fig. 4a) and reproducible between batches (Supplementary Fig. 20) . Associating >150,000 genetic variants (MAF > 20%) with the proportion of eight major immune cell populations, we identified a SNP (chr10:3791224) significantly associated (P = 1.03 × 10 −5 , FDR < 0.05) with the proportion of natural killer (NK) cells (Fig. 4b) .
Across 23 donors, we conducted an eQTL analysis to map genetic variants associated with expression variability in each major immune cell type. We found a total of 32 local eQTLs (±100 kb, FDR < 0.1), 22 of which were detected in only one cell type (Fig. 4c and Supplementary  Table 3 ). Previously reported local eQTLs from bulk CD14 + monocytes, CD4 + T cells, and lymphoblastoid cell lines were more significantly associated with gene expression in the most similar cell types (cM, T H , and B cells, respectively) than other cell types (Fig. 4d) . We used an inverse variance weighted meta-analysis to identify genes with pan-cell-type eQTLs, including those in the major histocompatibility complex (MHC) class I antigen presentation pathway, such as, ERAP2 (P < 3.57 × 10 −32 , meta-analysis), which encodes an aminopeptidase known to cleave viral peptides 20 , and HLA-C (P < 1.74x10 −29 , meta-analysis), which encodes the MHC class I heavy chain (Fig. 4e) . HLA-DQA1 has local eQTLs only in some cell types (P < 2.11 × 10 −15 , Cochran's Q) while HLA-DQA2 has local eQTLs in all antigen presentation cells (P < 1.02 × 10 −43 , Cochran's Q). Among other cell-type-specific local eQTLs are CD52, a gene ubiquitously expressed in leukocytes, which only has eQTLs in monocyte populations, and DIP2A, a gene with an eQTL only in NK cells, which is associated with immune response to vaccination in peripheral blood 21 . These results demonstrate the ability of multiplexed dscRNA-seq to characterize inter-individual variation in immune response and when integrated with genetic data, reveal cell-type-specific genetic control of gene expression, which would be undetectable when bulk tissues are analyzed.
The capability to demultiplex and identify doublets using natural genetic variation reduces the per-sample and per-cell library preparation cost of single-cell RNA-sequencing, removes the need for synthetic barcodes or split-pool strategies [22] [23] [24] [25] [26] , and allows the capture of biological variability among individual samples while limiting unwanted technical variability. We find the optimal number of samples to multiplex is ~20, based on sample processing time and empirical doublet rates of current microfluidic devices, and anticipate that number to increase with automated sample handling and lower doublet rates.
Compared to sorting known cell types followed by bulk RNA-seq, multiplexed dscRNA-seq is a more efficient and unbiased method for obtaining cell-type-specific immune traits 27 . Demuxlet enables reliable estimation of cell type proportion, recovers cell-typespecific transcriptional response to stimulation, and could facilitate further genetic and longitudinal analyses in relevant cell types and conditions across a range of sampled individuals, including between healthy controls and patients [28] [29] [30] . While demuxlet could in principle be applied to sequencing solid tissue, standardizing sample processing and preservation remain major challenges. Although we developed demuxlet specifically for RNA-sequencing, we anticipate that the computational framework could be easily extended to other singlecell assays where synthetic barcodes or natural genetic variation are measured by sequencing.
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where q cvi is a phred-scale quality score of the observed base call. We use the standard 10× pipeline to process the raw reads which estimates the phred-scale quality score based on the alignment of each read to the reference human transcriptome using the STAR aligner 31 . We allow uncertainty of observed genotypes at the v-th variant for the s-th sample using P g sv g sv
Data , the posterior probability of a possible genotype g given external DNA data Data sv (e.g., sequence reads, imputed genotypes, or array-based genotypes). If genotype likelihood Pr(Data sv |g) is provided (e.g., unphased sequence reads) instead, it can be converted to a posterior probability scale using P g g Screening for droplets containing multiple samples. To identify doublets, we implement a mixture model to calculate the likelihood that the sequence reads originated from two individuals, and the likelihoods are compared to determine whether a droplet contains cells from one or two samples. If sequence reads from the c-th droplet originate from two different samples, s 1 , s 2 with mixing proportions (1 − α):α, then the likelihood in (1) can be represented as the following mixture distribution 8 ,
To reduce the computational cost, we consider discrete values of a a a ∈ { } 1 ,..., M (e.g., 5 − 50% by 5%). We determine that it is a doublet between samples s 1 , s 2 if and only if max ( , and less confident droplets are classified as ambiguous. While we consider only doublets for estimating doublet rates, we remove all doublets and ambiguous droplets to conservatively estimate singlets. Supplementary Figure 8 illustrates the distribution of singlet, doublet likelihoods and the decision boundaries when t = 2 was used.
Theoretical expectation of deconvoluting singlets. The theoretical distribution of expected singlets with multiplexing ( Supplementary Fig. 2 ) is as follows. Let d o (e.g., 0.01) be the proportion of true multiplets when x o (1,000) cells are loaded when multiplexing was not used. Then the expected multiplet rates when x cells are loaded can be modeled exponentially as
Let α be the fraction of true singlets incorrectly classified as non-singlets (i.e., doublet or ambiguous), and α be the fraction of multiplets correctly classified as non-singlets. When multiplexing x cells equally from n samples, the expected multiplet rates are d(x), and 1 n d x ( ) are expected to be undetectable doublets mixed between the cells from the same sample. Therefore, the overall effective multiplet rate is n n
Similarly, the expected number of correctly identified singlets becomes Dependence of demultiplexing performance on experimental design parameters. The demuxlet 'plp' option was used to generate a pileup format of 6,145 cells from one well of PBMC 10× data. The reads in the pileup were then modified to reflect the genotypes of individuals sampled from the 1000 Genomes Phase 3 cohort. The pileup was downsampled to obtain different numbers of read-overlapping exonic SNPs (ranging from 5,000 to 100,000) for the whole cohort. To create simulated doublets, we randomly sampled and merged pairs of barcodes within a data set, resulting in a 5% doublet rate in the original data. For simulations with related individuals, we simulated transcriptomes from eight individuals in 1000 Genomes with varying degrees of relatedness, ranging from unrelated to parent-child (HG00146, HG00147, HG00500, HG00501, HG00502, HG00512, HG00514, and HG00524).
Isolation and preparation of PBMC samples. Informed consent was obtained from all patients sequenced in this study. Peripheral blood mononuclear cells were isolated from patient donors, Ficoll separated, and cryopreserved by the UCSF Core Immunologic Laboratory (CIL). PBMCs were thawed in a 37 °C water bath, and subsequently washed and resuspended in EasySep buffer (STEMCELL Technologies). Cells were treated with DNaseI and incubated for 15 min at RT before filtering through a 40-µum column. Finally, the cells were washed in EasySep and resuspended in 1× PBMS and 0.04% bovine serum albumin. Cells from eight donors were then re-concentrated to 1 M cells per mL and then serially pooled. At each pooling stage, 1 M cells per mL were combined to result in a final sample pool with cells from all donors.
IFN-b stimulation and culture.
Prior to pooling, samples from eight individuals were separated into two aliquots each. One aliquot of PBMCs was activated by 100 U/mL of recombinant IFN-β (PBL Assay Science) for 6 h according to the published protocol 16 . The second aliquot was left untreated. After 6 h, the eight samples for each condition were pooled together in two final pools (stimulated cells and control cells) as described above.
Fluorescence-activated cell sorting and analysis. 1 M PBMCs from each donor were stained using standard procedure (30 min, 4 °C) with the following surface antibody panel (CD3-PerCP clone SK7 (BioLegend), CD4-APC clone OKT4 (BioLegend), CD8-BV570 clone RPA-T8 (BioLegend), CD14-FITC clone 63D3 (BioLegend), CD19-BV510 clone SJ25C1 (BD), and Ghost dye A710 viability stain (Tonbo)) (Life Sciences Reporting Summary). Samples were then analyzed and sorted using a BD FACSAria Fusion instrument at the UCSF flow cytometry core. To calculate cell type proportions, the number of events in each of CD3 + CD4 + CD8 -(CD4 + T cells), CD3 + CD4 -CD8 + (CD8 + T cells), CD3 -CD19 + (B cells), and CD3 -CD14 + (monocytes) were divided by the sum of events in these gates (Supplementary Fig. 21 ).
Quantitative polymerase chain reaction analysis. RNA was isolated from sorted CD4 + T cells following the RNeasy micro kit protocol (QIAGEN), and cDNA was prepared using MultiScribe Reverse Transcriptase (Applied Biosystems cat #4368814). The qPCR primers were chosen from the PrimerBank reference when available 32 . Each sample was run in triplicate with the Luminaris HiGreen qPCR kit (Thermo Scientific #K0992) according to standard protocol using a Roche Light Cycler 96 instrument and fold change was calculated from ∆∆CT between control and stimulated samples with GAPDH as a reference gene.
Droplet-based capture and sequencing. Cellular suspensions were loaded onto the 10× Chromium instrument (10× Genomics) and sequenced as described in Zheng et al. 7 . The cDNA libraries were sequenced using a custom program on ten lanes of Illumina HiSeq2500 Rapid Mode, yielding 1.8 B total reads and 25 K reads per droplet. At these depths, we recovered >90% of captured transcripts in each sequencing experiment.
Bulk isolation and sequencing. PBMCs from lupus patients were isolated and prepared as described above. Alignment and initial processing of single-cell sequencing data. We used the CellRanger v1.1 and v1.2 software with the default settings to process the raw FASTQ files, align the sequencing reads to the hg19 transcriptome, and generate a filtered UMI expression profile for each droplet 7 . The raw UMI counts from all cells and genes with nonzero counts across the population of cells were used to generate t-SNE profiles.
Cell type classification and clustering. To identify known immune cell populations in PBMCs, we used the Seurat package to perform unbiased clustering on the 2.7 k PBMCs from Zheng et al. 7 , following the publicly available Guided Clustering Tutorial 7,35 . The FindAllMarkers function was then used to find the top 20 markers for each of the eight identified cell types. Cluster averages were calculated by taking the average raw count across all cells of each cell type. For each singlet, we calculated the Spearman correlation of the raw counts of the marker genes and the cluster averages, and assigned each singlet to the cell type to which it had maximum correlation.
Differential expression analysis. Demultiplexed individuals were used as replicates for differential expression analysis. For each gene, raw counts were summed for each individual. We used the DESeq2 package to detect differentially expressed genes between control and stimulated conditions 36 . Genes with baseMean > 1 were filtered out from the DESeq2 output, and the qvalue package was used to calculate FDR < 0.05 (ref. 37 ).
Estimation of inter-individual variability in PBMCs.
For each individual, we found the mean expression of each gene with nonzero counts. The mean was calculated from the log 2 single-cell UMI counts normalized to the median count for each cell. To measure inter-individual variability, we then calculated the variance of the mean expression across all individuals. Lin's concordance correlation coefficient was used to compare the agreement of observed data and synthetic replicates. Synthetic replicates were generated by sampling without replacement either from all cells or cells matched for cell type proportion. Cell-type-specific variability estimated as the correlation between synthetic replicates was compared to variability estimates from 23 biological replicates of bulk IFN-stimulated monocyte-derived dendritic cells. Protein coding genes (407/414) originally measured using Nanostring (a hybridization based PCRfree quantification method) were assessed, and variability in the bulk data set was estimated as repeatability using a linear mixed model 16, 38 .
Estimation of inter-individual variability within cell types. For each cell type, we generated two bulk equivalent replicates for each individual by summing raw counts of singlets sampled without replacement. We used DESeq2 to generate variance-stabilized counts across all replicates. To filter for expressed genes, we performed all subsequent analyses on genes with 5% of samples with > 0 counts. The correlation of replicates was performed on the log 2 -normalized counts. Pearson correlation of the two replicates from each of the eight individuals was used to find genes with significant inter-individual variability.
Quantitative trait mapping in major immune cell types. Genotypes were imputed with EAGLE 39 and filtered for MAF > 0.2, resulting in a total of 189,322 SNPs. Cell type proportions were calculated as number of cells for each cell type divided by the number of total cells for each person. Linear regression was used to test associations between each genetic variant and cell-type proportion with the Matrix eQTL software 40 . Cis-eQTL mapping was conducted in each cell type separately. All genes with at least 50 UMI counts in 20% of the individuals in all PBMCs were tested for each cell type, resulting in a total of 4,555 genes. Variance-stabilized and log-normalized gene expression was calculated using the 'rlog' function of the DESeq2 package 36 . All variants within a window of 100 kbp of each gene were tested with linear regression using Matrix eQTL 40 . Batch information for each sample as well as the first three principal components of the expression matrix were used as covariates.
Life Sciences Reporting Summary. Further information on experimental design is available in the Life Sciences Reporting Summary.
Data availability. Single-cell and bulk RNA-sequencing data have been deposited in the Gene Expression Omnibus under the accession number GSE96583. Demuxlet software is freely available at https://github.com/statgen/demuxlet.
